What constitutes evidence in hospital new drug decision making?

Social Science and Medicine

Volumn 58, Issue 9, 2004, Pages 1757-1766

  Jenkings, K Neil ^a,b   Barber, Nick ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Decision making; Drug; Drug and Therapeutics Committee; Evidence based medicine; Formulary; UK

Indexed keywords

NEW DRUG;

DRUG PRESCRIBING;

ARTICLE; DATA ANALYSIS; DRUG COST; DRUG INDUSTRY; EVIDENCE BASED MEDICINE; HEALTH CARE FINANCING; HEALTH CARE POLICY; HOSPITAL PHARMACY; LANGUAGE; MEDICAL DECISION MAKING; PRESCRIPTION; TAPE RECORDER;

EID: 1442311075     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0277-9536(03)00373-3     Document Type: Article

References (22)

1. Abraham, J. (1995). Science, politics and the pharmaceutical industry. (p. 50) London: UCL Press.
2. Berg M., Meulen R.T., v.d. Burg M. Guidelines for appropriate care. The importance of empirical normative analysis Health Care Analysis. 9:2001;77-99.
3. Boden, D. (1994). The business of talk: organizations in action. (p. 35) Cambridge: Polity Press.
4. Collier J., Foster J. Management of a restricted drugs policy in hospital. The first five years' experience The Lancet. 1:1985;331-333.
5. Cooke J., Walley T., Drummond M.F. The use of health economics by hospital pharmacist decision makers. Pharmaceutical Journal. 259:1997;779-781.
6. Cotter S.M., Barber N.D., McKee M. A survey of clinical pharmacy services in UK National Health Service hospitals. American Journal of Hospital Pharmacy. 51:1994;2676-2684.
7. Cribb A., Barber N. Good prescribing, the limits of technique. Health Care Analysis. 5:1997;292-298.
8. Davis P. Managing medicines. Public policy and therapeutic drugs:1997;Open University Press, Buckingham.
9. Department of Health. (2002). www.doh.gov.uk/prescriptionstatistics/ index.htm.
10. DHSS. (1988). Health services development: resources, assumptions and planning guidelines. HC(88)43/FPN(88)457.
11. Evidence Based Medicine Working Group (EMB). (1992). Evidence based medicine: a new approach to teaching the practice of medicine. Journal of the American Medical Association, 268, 420-425.
12. Fitzpatrick R.W. Is there a place for drug and therapeutic committees in the NHS? European Hospital Pharmacy. 3:1997;143-147.
13. Garfinkel H. Studies in ethnomethodology. 1967;Engelwood Cliffs, Prentice-Hall, NJ.
14. Grabowski H., Mullins C.D. Pharmacy benefit management cost effectiveness analysis and formulary decisions. Social Science & Medicine. 45:1997;535-544.
15. Gray J.A.M. Evidence-based healthcare how to make health policy and management decision. 1997;Churchill Livingston, London.
16. Joshi M.P., Williams A., Petrie J.C. Hospital formularies in 1993. Where, why and how? The Pharmaceutical Journal. 253:1994;63-65.
17. Leach R.H., Leach S.J. Drug and therapeutic committees in the United Kingdom in 1992. Pharmaceutical Journal. 253:1994;61-63.
18. Luff, P., Hindmarsh, J., & Heath, C. (2000). Workplace studies: recovering work practice and informing system design. (p. 6) Cambridge: Cambridge University Press.
19. Raeithel A. On the ethnography of cooperative work. Engestrom Y., Middleton D. Cognition and communication at work. 1996;321 Cambridge University Press, Cambridge.
20. Remington H. Formularies and drug and therapeutic committees. The Pharmaceutical Journal. 247:1991;140-141.
21. Singer P.A., Martin D.K., Giacomini M., Purdy L. Priority setting for new technologies in medicine. Qualitative case study BMJ. 321:2000;1316-1318.
22. Sutters C.A. The management of a hospital formulary. Journal of Clinical Pharmacy and Therapeutics. 15:1990;59-76.